Bioelectronics Corp Stock Profit Margin

BIEL Stock  USD 0.0003  0.0001  50.00%   
Bioelectronics Corp fundamentals help investors to digest information that contributes to Bioelectronics Corp's financial success or failures. It also enables traders to predict the movement of Bioelectronics Pink Sheet. The fundamental analysis module provides a way to measure Bioelectronics Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bioelectronics Corp pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Bioelectronics Corp Company Profit Margin Analysis

Bioelectronics Corp's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Profit Margin

 = 

Net Income

Revenue

X

100

More About Profit Margin | All Equity Analysis

Current Bioelectronics Corp Profit Margin

    
  (0.18) %  
Most of Bioelectronics Corp's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bioelectronics Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition

Based on the latest financial disclosure, Bioelectronics Corp has a Profit Margin of -0.1801%. This is 98.39% lower than that of the Healthcare sector and 96.7% lower than that of the Medical Devices industry. The profit margin for all United States stocks is 85.82% lower than that of the firm.

Did you try this?

Run Insider Screener Now

   

Insider Screener

Find insiders across different sectors to evaluate their impact on performance
All  Next Launch Module

Bioelectronics Fundamentals

About Bioelectronics Corp Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Bioelectronics Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioelectronics Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioelectronics Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Bioelectronics Pink Sheet

Bioelectronics Corp financial ratios help investors to determine whether Bioelectronics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioelectronics with respect to the benefits of owning Bioelectronics Corp security.